Take5Care+: A Self-management Educational Intervention to Support the Haematology Patients' Journey Following a Neoplastic Diagnosis.
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 20
- 主要终点
- Feasibility of the intervention
研究概览
简要总结
Patients who are diagnosed with haematological malignancies may feel that they have little or no control over their health which can be distressing. However, a diagnosis can also be the opportunity for a "teachable moment" during which patients are more likely to open to behaviour change, which can positively impact on their health and wellbeing. Take Five to Age Well (Take Five) was designed to empower people to achieve effective, long-term self-management of health by introducing healthy habits in 30 days.
In collaboration with Northampton General Hospital (NGH) the current study will recruit newly diagnosed haematology patients who are either being actively monitored or only on non-intensive treatment to take part in a self-managed behaviour change intervention. This is primarily a feasibility study to inform main trials in the future.
The main aim of the research is:
- To assess the feasibility of using Take5Care+ with patients newly diagnosed with indolent or chronic haematological malignancies, recruited via hospital departments
There are also secondary aims, including: 2. To assess the impact of participating in Take5Care+ on patients' self-reported health and well-being, healthy behaviours and sense of control, knowledge and management of health 3. To explore the perceptions of patients and clinicians about their participation in the Take5Care+ Patients who wish to take part will be asked to fill out a survey at baseline, complete a "challenge" where they commit to a healthy action for 30 days, fill out a second survey immediately after and a third survey three months later. Patients may also consent to participating in an interview post-challenge. Giving consent and completing the baseline survey will take place in NGH but the challenge is self-managed at home and remotely supported. Survey 2, Survey 3 and the optional interviews are also carried out online or over the phone.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •18 years or older.
- •Have been diagnosed within the last 3 months with one of the eligible conditions listed in Table
- •Be managed with either:
- •Active monitoring, or
- •Non-intensive oral therapy, defined as outpatient oral regimens that do not require inpatient initiation and have lower expected toxicity (e.g., BTK inhibitors, TKIs, interferon, lenalidomide, hydroxycarbamide, low-dose alkylators).
- •Have ECOG Performance Status 0-
- •Be able to give informed consent.
- •Be judged suitable for participation by the treating clinician.
排除标准
- •Receiving intensive chemotherapy, immunotherapy, IV combination regimens, cellular therapy, radiotherapy or treatments requiring inpatient initiation.
- •Received or expected to require regular blood product transfusions
- •Life expectancy <12 months.
- •Acutely terminal illness.
- •Cognitive impairment that would prevent the patient from giving informed consent, or reliably completing the daily action and follow-up assessments
- •Pregnant or lactating.
- •Currently participating in a CTIMP or other behavioural research intervention.
- •Unstable, uncontrolled, or severe comorbidities:
- •Uncontrolled heart failure, unstable angina, or MI <3 months.
- •Stroke/TIA <3 months.
- •Severe/unstable COPD or asthma with recent exacerbations.
- •Poorly controlled diabetes
- •Severe psychiatric illness interfering with participation.
- •Concurrent active malignancy requiring systemic therapy.
- •Any other condition that, in the investigator's judgement, would compromise safe participation.
研究组 & 干预措施
Take5Care+ treatment
Newly diagnosed haematology patients will be recruited to take part in a self-managed behaviour change intervention. Participants commit to a behavioural action (a "healthy habit") from a predetermined list for 30 days.
干预措施: Take5Care+ (Other)
结局指标
主要结局
Feasibility of the intervention
时间窗: From beginning of study (0 weeks) until data collection is completed (up to 10 months)
* % of patients who are recruited from possible participant pool (anonymous) during recruitment period (recruitment numbers = number of participants/number of total participants) * % of patients who withdraw from study via study log (study attrition = number of withdrawals/number of total participants who consent into study) * % of patients who withdraw from survey during survey completion (survey attrition = number of incomplete surveys/number of times survey is started) All data is secondary data and will not require participant input.
Qualitative exploration of feasibility of study
时间窗: Directly after participant completes the intervention (at 4 weeks)
* Optional semi-structured interviews with participants, analysed using thematic analysis * Qualitative interviews with healthcare professionals, analysed using thematic analysis
次要结局
- Self-reported behaviours of healthy behaviour(Survey 1 will be at 0 weeks, survey 2 will be at 4 weeks and survey 3 will be at 16 weeks)
- Self-reported health(Survey 1 will be at 0 weeks, survey 2 will be at 4 weeks and survey 3 will be at 16 weeks)
- Self-reported adherence to Take5Care+ actions(Survey 2 will be at 4 weeks and Survey 3 at 16 weeks.)
- Subjective perception of health(Survey 1 will be at 0 weeks, survey 2 will be at 4 weeks and survey 3 will be at 16 weeks)
- Explore perceptions of patients and clinicians(Directly after the intervention (at 4 weeks))
研究者
Jitka Vseteckova
Chief Investigator
Open University